Skip to main content

Introduction: The Scope of the Problem with Diminished Ovarian Reserve

  • Chapter
  • First Online:
  • 603 Accesses

Abstract

The observation throughout the recorded human history confirmed that the fecundability and the fecundity rates decline with advancing female age. It seems that fertility decline in females may start as early as the late 20s to early 30s. Female age is the most important factor for achieving live birth with assisted reproductive technologies. Many women also postpone pregnancy due to various factors as evidenced by the registry data that the age of first birth in women is increasing around the globe. Hence, many such women are attempting conception during their reproductive years when steep fertility decline is expected. This fertility decline with aging is commonly associated with diminished ovarian reserve (DOR) and diminished oocyte/embryo quality. Since the controlled ovarian stimulations became a norm in assisted reproductive technology (ART) cycles, it has been realized that some women just do not respond well to ovarian stimulation. Therefore, poor ovarian response (POR) generalization has been proposed in order to unify such criteria for relevant studies. The Bologna criteria is based on response to maximum dose conventional stimulation, advanced reproductive age at or above 40, somewhat wide ranges of ovarian reserve markers, and prior history of POR. Recently, another POR criteria was proposed by POSEIDON group bringing somewhat more individualization, focusing on prognosis. Many such women are in fact suffering from DOR and show various prognoses.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society for Reproductive Endocrinoogy, Infertility. Electronic address, ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society for Reproductive Endocrinology, Infertility. Optimizing natural fertility: a committee opinion. Fertil Steril. 2017;107(1):52–8.

    Google Scholar 

  2. Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63.

    Google Scholar 

  3. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015;103(3):e9–e17.

    Google Scholar 

  4. Pastore LM, Christianson MS, Stelling J, Kearns WG, Segars JH. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR. J Assist Reprod Genet. 2018;35(1):17–23.

    Article  Google Scholar 

  5. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS). Reporting of pregnancy success rates from Assisted Reproductive Technology (ART) programs. Federal Register Notices. 2015;8(165):51811–9. https://www.gpo.gov/fdsys/pkg/FR-2015-08-26/pdf/2015-21108.pdf.

    Google Scholar 

  6. Center for Disease Control and Prevention. Archived ART Reports and Spreadsheets. 2015 and 2005.

    Google Scholar 

  7. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616–24.

    Article  CAS  Google Scholar 

  8. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril. 2011;96(5):1058–61.e7.

    Article  Google Scholar 

  9. Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, et al. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Mullerian hormone and response to controlled ovarian stimulation. Fertil Steril. 2010;94(5):1775–81.

    Article  CAS  Google Scholar 

  10. Ruess ML, Kline J, Santos R, Levin B, Timor-Tritsch I. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol. 1996;174(2):624–7.

    Article  CAS  Google Scholar 

  11. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002;77(2):328–36.

    Article  Google Scholar 

  12. Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod. 2005;20(11):3178–83.

    Article  CAS  Google Scholar 

  13. Rotterdam, Eshre Asrm-Sponsored Pcos Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.

    Google Scholar 

  14. Haadsma ML, Bukman A, Groen H, Roeloffzen EM, Groenewoud ER, Heineman MJ, et al. The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod. 2007;22(7):1925–31.

    Article  CAS  Google Scholar 

  15. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.

    Article  CAS  Google Scholar 

  16. Poseidon Group, Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452–3.

    Google Scholar 

  17. Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, et al. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31(2):370–6.

    PubMed  Google Scholar 

  18. Alviggi C, Pettersson K, Longobardi S, Andersen CY, Conforti A, De Rosa P, et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol. 2013;11:51.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orhan Bukulmez .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bukulmez, O. (2020). Introduction: The Scope of the Problem with Diminished Ovarian Reserve. In: Bukulmez, O. (eds) Diminished Ovarian Reserve and Assisted Reproductive Technologies. Springer, Cham. https://doi.org/10.1007/978-3-030-23235-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-23235-1_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-23234-4

  • Online ISBN: 978-3-030-23235-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics